ArticleJCO clinical cancer informatics2021

Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.

Jeremy Mason et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.